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Abstract 
Background: Conservation Breeding Programs (CBP's) are playing an important role in the protection of 
critically endangered anuran amphibians, but for many species recruitment is not successful enough to 
maintain captive populations, or provide individuals for release. In response, there has been an increasing 
focus on the use of Assisted Reproductive Technologies (ART), including the administration of 
reproductive hormones to induce gamete release followed by in vitro fertilisation. The objective of this 
study was to test the efficacy of two exogenous hormones to induce gamete release, for the purpose of 
conducting in vitro fertilisation (IVF), in one of Australia's most critically endangered frog species, 
Pseudophryne corroboree.Methods: Male frogs were administered a single dose of either human 
chorionic gonadotropin (hCG) or luteinizing hormone-releasing hormone (LHRHa), while female frogs 
received both a priming and ovulatory dose of LHRHa. Spermiation responses were evaluated at 3, 7, 12, 
24, 36, 48, 60 and 72 h post hormone administration (PA), and sperm number and viability were quantified 
using fluorescent microscopy. Ovulation responses were evaluated by stripping females every 12 h PA for 
5 days. Once gametes were obtained, IVF was attempted by combining spermic urine with oocytes in a 
dilute solution of simplified amphibian ringer (SAR).Results: Administration of both hCG and LHRHa 
induced approximately 80% of males to release sperm over 72 h. Peak sperm release occurred at 12 h PA 
for hCG treated males and 36 h PA for LHRHa treated males. On average, LHRHa treated males released a 
significantly higher total number of live sperm, and a higher concentration of sperm, over a longer period. 
In female frogs, administration of LHRHa induced approximately 30% of individuals to release eggs. On 
average, eggs were released between 24 and 48 h PA, with a peak in egg release at 36 h PA. IVF resulted 
in a moderate percentage (54.72%) of eggs being fertilised, however all resultant embryos failed prior to 
gastrulation.Conclusions: Hormone treatment successfully induced spermiation and ovulation in P. 
corroboree, but refinement of gamete induction and IVF techniques will be required before ART protocols 
can be used to routinely propagate this species. © 2010 Byrne and Silla; licensee BioMed Central Ltd 
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Hormonal induction of gamete release, and in-
vitro fertilisation, in the critically endangered
Southern Corroboree Frog, Pseudophryne
corroboree
Phillip G Byrne1*†, Aimee J Silla2†
Abstract
Background: Conservation Breeding Programs (CBP’s) are playing an important role in the protection of critically
endangered anuran amphibians, but for many species recruitment is not successful enough to maintain captive
populations, or provide individuals for release. In response, there has been an increasing focus on the use of
Assisted Reproductive Technologies (ART), including the administration of reproductive hormones to induce
gamete release followed by in vitro fertilisation. The objective of this study was to test the efficacy of two
exogenous hormones to induce gamete release, for the purpose of conducting in vitro fertilisation (IVF), in one of
Australia’s most critically endangered frog species, Pseudophryne corroboree.
Methods: Male frogs were administered a single dose of either human chorionic gonadotropin (hCG) or
luteinizing hormone-releasing hormone (LHRHa), while female frogs received both a priming and ovulatory dose of
LHRHa. Spermiation responses were evaluated at 3, 7, 12, 24, 36, 48, 60 and 72 h post hormone administration
(PA), and sperm number and viability were quantified using fluorescent microscopy. Ovulation responses were
evaluated by stripping females every 12 h PA for 5 days. Once gametes were obtained, IVF was attempted by
combining spermic urine with oocytes in a dilute solution of simplified amphibian ringer (SAR).
Results: Administration of both hCG and LHRHa induced approximately 80% of males to release sperm over 72 h.
Peak sperm release occurred at 12 h PA for hCG treated males and 36 h PA for LHRHa treated males. On average,
LHRHa treated males released a significantly higher total number of live sperm, and a higher concentration of sperm,
over a longer period. In female frogs, administration of LHRHa induced approximately 30% of individuals to release
eggs. On average, eggs were released between 24 and 48 h PA, with a peak in egg release at 36 h PA. IVF resulted in
a moderate percentage (54.72%) of eggs being fertilised, however all resultant embryos failed prior to gastrulation.
Conclusions: Hormone treatment successfully induced spermiation and ovulation in P. corroboree, but refinement
of gamete induction and IVF techniques will be required before ART protocols can be used to routinely propagate
this species.
Background
Environmental change driven by anthropogenic activities
is causing unprecedented rates of species extinction,
presenting a major threat to global biodiversity [1].
Among vertebrates, all classes have suffered high
extinction rates, but amphibians have been most
severely impacted. Based on recent estimates, more than
one-third of the worlds amphibians are threatened with
extinction [2,3], and almost one-half of the remaining
species are in a state of decline [2]. In response to this
crisis, the international Amphibian Conservation Action
Plan (ACAP), devised in 2005, urged the establishment
of captive assurance colonies for threatened species
[4,5]. In accordance with this recommendation, a large
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number of institutions worldwide have initiated captive
breeding programmes for declining and endangered
amphibians. However, in almost all cases, breeding
attempts have failed due to the inherent difficulties asso-
ciated with simulating the complex combination of
social and environmental factors that trigger amphibians
to breed [6,5]. In reaction to this captive breeding crisis,
there has been a growing interest in determining
whether threatened amphibians can be propagated, and
genetically managed, using assisted reproductive tech-
nologies (ART)[5,7,8].
One component of ART is the artificial manipulation
of reproductive events using exogenous hormones. Spe-
cifically, males and females are administered hormones
to stimulate the production and release of gametes
(spermatozoa and oocytes), which are then used to gen-
erate embryos via in vitro fertilisation (IVF), also
referred to as artificial fertilisation (AF) [5]. Among
anurans (frogs and toads), it has been known for several
decades that exogenous gonadotropins, and gonadotro-
pin-releasing hormones, can be used to induce both
sperm release (spermiation) and oocyte release (ovula-
tion) [9-12]. Pituitary extracts are an effective source of
amphibian gonadotropins and such preparations have
been successfully used to induce gamete release in var-
ious anuran species, including Bufo arenarum, Rana
pipiens, Hyla regilla and Eleutherodactylus coqui
[9,10,13-16]. However, the use of pituitary extracts is
now strongly discouraged due to a high risk of pathogen
transmission [5,7], and because production of pituitary
preparations requires the euthanasia of large numbers of
reproductively mature anurans [17]. An alternative
approach is the use of synthetic hormones, in particular,
commercially available analogues of luteinizing-hormone
releasing hormone (LHRH) and human chorionic gona-
dotropin (hCG) [8,17-19].
Luteinizing-hormone releasing hormone is a hypotha-
lamic hormone that acts by stimulating the anterior
pituitary to synthesize and release natural luteinizing
hormone (LH), which in turn stimulates gonadal activ-
ity. In contrast, hCG acts by mimicking LH, due to
identical alpha and shared beta subunits [20], bypassing
the hypothalamic-pituitary-gonadal axis to exert a direct
influence on the gonads [21]. Evidence that synthetic
analogues of LHRH and hCG can successfully induce
gamete release has been obtained for a broad diversity
of anuran species [7,17,18,22-26], but the efficacy of
these hormones has been found to vary considerably.
For example, LHRHa is significantly more effective than
hCG at stimulating ovulation in Eleutherodactylus coqui
[17], but hCG is highly effective at stimulating ovulation
in Xenopus laevis [26].
Although there is still much to learn about the relative
efficacy of hCG and LHRHa across species, baseline
knowledge concerning their potency has permitted IVF
to be attempted in a small, but growing number of
anuran families, including the bufonidae [8], pipidae
[26] and myobatrachidae [27]. Surprisingly, however,
almost all anuran IVF studies conducted to date have
refrained from artificially fertilizing oocytes using hor-
monally induced sperm, instead opting to use sperm
obtained from testes macerates [13,27-29]. The benefit
of conducting IVF using testes macerates is that sperm
can be obtained in high concentrations, and can also be
acquired at the exact moment when females begin ovu-
lating, eliminating the need for sperm storage [19].
Given these practical advantages, euthanizing males for
the purpose of IVF might be useful in common species,
but this approach cannot be justified in endangered spe-
cies where individual animals are of high genetic value
[5,7].
To date, few studies have attempted IVF in anurans
using hormonally induced gametes collected from live
animals, and outcomes have been highly variable. For
example, Waggener and Carrol [22] achieved 100% ferti-
lisation success in the leptodactylid frogs Lepidobatra-
chus laevis and L. illanensis [22], but Browne et al. [8]
reported a mean fertilisation success of 12.7% in the
endangered toad Bufo baxteri. This extreme variance in
IVF success, which is probably related to species-specific
differences in reproductive mode and physiology, sug-
gests that protocols for combining hormonally induced
gametes are not readily transferable between species
[19]. Given this inherent level of unpredictability, there
is a need to develop techniques for collecting and com-
bining gametes obtained from live individuals. In parti-
cular, there is an urgent need to develop these protocols
for endangered species [7,8].
The southern corroboree frog Pseudophryne corro-
boree, is one of Australia’ s most critically endangered
frog species [30]. Of the species known to be extant in
Australia, P. corroboree was ranked by the Australasian
Regional Association of Zoological Parks and Aquaria as
the highest priority anuran requiring ex-situ conserva-
tion [31]. The distribution of P. corroboree is highly
restricted, with the species confined to a linear distance
of 51 km within subalpine regions of Koscuiszko
National Park [32]. According to recent field surveys,
there are currently less than 50 individuals remaining at
natural breeding sites, and the species is predicted to go
extinct in the wild within the next ten years [33]. Popu-
lation declines in P. corroboree were first observed in
the 1980’s, and since 1996 the species has been the
focus of an intensive management and recovery pro-
gramme [33,34]. Early management of the species con-
centrated on habitat protection, but more recently
efforts have turned towards the establishment of captive
assurance populations [33,35]. At present, multiple
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populations of P. corroboree are being maintained in
zoos and biological institutions throughout Australia,
but successful breeding and recruitment in captivity has
been limited. Despite this critical situation, there has
been no attempt to bolster captive breeding activity
using assisted reproductive technologies.
The aim of this study was twofold. First to test the
efficacy of using LHRH and hCG to induce spermiation,
and LHRH to induce ovulation, in captively reared P.
corroboree, and second, to test whether hormonally
induced sperm and oocytes can be used to generate
embryo’s via in-vitro fertilisation (IVF).
Methods
All research was conducted in compliance with the
Monash University Animal Ethics Committee (AEC),
permit number BSCI/2009/27.
Study population
Frogs were obtained from a captive colony maintained at
the Amphibian Research Centre (ARC) in Melbourne
Victoria. The captive colony was established by collecting
natural egg clutches from multiple populations through-
out the species range during the 2004 and 2005 breeding
seasons. The eggs were reared to maturity and housed in
indoor terrariums (150 × 43 × 38 cm) exposed to seaso-
nal fluctuations in temperature and photoperiod that
mimicked natural conditions. Frogs used in this study
were approximately 4-5 years old because sexual maturity
in P. corroboree is not reached until 3-4 years post-meta-
morphosis [36]. In total, the study involved 24 males and
25 females, but one male was not treated. In P. corroboree
phenotypic traits do not provide reliable indicators of sex.
Therefore, prior to commencement of the study all frogs
were genetically sexed using Amplified Fragment Length
Polymorphism (AFLP) analysis, with the presence of a
66 bp DNA marker (representing a Y chromosome
sequence) diagnostic for males [37,38].
Frogs were collected from the ARC and transported to
Monash University (Clayton campus) where they were
held for the duration of the study (January 29-April 9,
2009). On the day of collection, frogs were weighed and
snout-vent length measured before being randomly
assigned to same sex groups (n = 6 frogs per group, with
the exception of one female group that contained 7
frogs). Groups of individuals were housed in plastic
enclosures (360 mm × 200 mm × 170 mm), each contain-
ing a layer of fine gravel (~15 cm thick) covered with a
layer of sphagnum moss (~5 cm thick). Once a week,
containers were flushed with approximately 2 L of deioi-
nized water and frogs were fed ten-day old crickets (~200
per container). All containers were kept in a constant
temperature room maintained on a 17°C/12°C day/night
temperature cycle and a 14.5 h/9.5 h light/dark cycle.
Hormonal induction of spermiation
Males were administered a single dose of either 20 IU
per gram bodyweight hCG (chorolon®) (n = 6 males) or
5 μg per gram bodyweight LHRHa (Leuprorelin oxo-Pro-
His-Trp-Ser-Tyr-[d-leu]-Leu-Arg-Pro-NHEt: Lucrin®) (n =
11 males). These doses were selected because they
approximate doses previously found to induce gamete
release in anurans [5,22,24,39]. Hormones were diluted
in 100 μL of Simplified Amphibian Ringer (113 mM
NaCl, 2 mM KCl, 1.35 mM CaCl2, 1.2 mM NaHCO3)
and administered via subcutaneous injection into the
dorsal lymph sac. As a control for the injection and
handling procedures, a third group of frogs (n = 6) were
administered 100 μL of Simplified Amphibian Ringer
(SAR). Following hormone administration, frogs were
returned to plastic holding tanks (50 mm × 90 mm)
containing moist sponge hydrated with 5 mL of distilled
water. Under these conditions, frogs were sufficiently
hydrated to permit urine collection at each of the sam-
pling times.
Spermic urine was collected at 3, 7, 12, 24, 36, 48,
60 & 72 h post hormone administration (PA). The col-
lection method involved gently inserting the end of a
glass microcapillary tube (fire polished and cooled) into
the cloaca to stimulate urination. Immediately post col-
lection, the volume of urine collected was measured in
microlitres (μL), and the sample was then homogenized
with 5 μL of a 1:50 dilution of SYBR-14 (Invitrogen L-
7011), and then incubated in the dark for 7 min. Follow-
ing this, a 2 μL aliquot of propidium iodide (PI) was
then added and the solution was incubated in the dark
for a further 7 min. SYBR-14 and PI are membrane per-
manent DNA stains that are commonly used to quantify
sperm number and viability in anurans [39,40] and
other vertebrates [38]. SYBR-14 specifically stains the
DNA of live (viable) sperm, while PI specifically stains
the DNA of dead (non-viable) sperm. Under UV light,
live sperm (stained with SYBR-14) fluoresce bright
green, while dead sperm (stained with PI) fluoresce
bright red [41]. Immediately after staining, wet mount
slides were prepared and the viability of sperm was eval-
uated within 30 min using fluorescent microscopy at a
wavelength of 490 nm. For each sample, we calculated
the total sperm count, sperm concentration (number of
sperm/urine volume (μL) × 1000), and sperm viability
(the proportion of live/total sperm).
Hormonal induction of ovulation
Females were randomly allocated to one of two treat-
ment groups; a hormone treatment (n = 17 females)
administered LHRHa (Lucrin®), or a control treatment
(n = 8 females) administered Simplified Amphibian
Ringer (SAR). For the hormone treatment, a stock solu-
tion of Lucrin® was diluted in Simplified Amphibian
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Ringer to produce a final concentration of 100 μg mL-1.
Females received an anovulatory dose of 1 μg LHRHa
per gram bodyweight diluted in 100 μL of SAR adminis-
tered via subcutaneous injection into the dorsal lymph
sac. This dosage was administered to prime the ovary
without inducing ovulation [8,42]. Twenty-six hours
after administration of the ‘priming dose’, each female
received an ovulatory dose of 5 μg LHRHa per gram
bodyweight. For the control treatment, females were
administered 100 μL of SAR in place of the priming and
ovulatory doses. Following treatment, individual females
were placed into plastic enclosures (200 mm × 120 mm
× 90 mm) lined with moist sponge and sphagnum moss.
Individual animals were removed from their holding
tanks 12 h PA of the ovulatory dose and stripping
(expulsion of eggs from the oviducts) was attempted.
Stripping was facilitated by holding a frog with its legs
extended and gently applying pressure to the abdomen
in a craniocaudal direction [21,43]. Stripping was
attempted every 12 h ± 0.5 h for a period of five days.
In-vitro fertilisation (IVF)
At each sampling time, any eggs expelled from a female
were placed in an individual dry Petri dish and IVF was
conducted using available spermic urine samples. An ali-
quot of approximately 170 μL of pooled spermic urine
was activated in approximately 100 μL 1:4 SAR. Sperm
concentrations used for IVF ranged between 1.14 × 102
and 2.87 × 102. The sperm solution was pipetted directly
onto the oocytes and the dish was agitated for one min-
ute. Each dish was enclosed within a petri dish and left
to develop in a constant temperature room set to 10°C.
Developing embryos were supplied with 100 μL of deio-
nised water at 12 h, and a further 1000 μL at 24 h post
fertilisation. Fertilisation success was calculated as the
proportion of eggs at Gosner stage 4 to 6 [44] approxi-
mately 12 h post application of spermic urine to the
oocytes. Embryonic development was checked every 6-
12 h for a period of 7 days, and developmental stage
quantified, using a stereo dissecting microscope.
Statistical analyses
The number of males that released sperm was compared
between experimental treatments (LHRHa versus hCG),
and between each experimental treatment and the con-
trol (hCG versus control, LHRHa versus control), using
Fisher’s exact tests. All comparisons were one-tailed due
to the expectation of a positive treatment response. Com-
parison of mean total sperm count and mean total sperm
concentration over the 72 h sampling period was made
between treatments using Welch ANOVA’s, due to
unequal variance. Calculations of total sperm concentra-
tion only included sampling times in which sperm were
released. Comparisons of sperm count and sperm
concentration over time were made between treatments
using repeated measures MANOVA’s, with the main fac-
tors set as hormone treatment, and the within subject
factors set as time. The MANOVA’s were based on 6
equally spaced time intervals: 12 h, 24 h, 36 h, 48 h, 60 h
and 72 h PA. Because the data violated the assumption of
sphericity (Mauchly’s test: P < 0.05), univariate analyses
were corrected, and degrees of freedom adjusted, using
the Greenhouse-Geisser method. The mean proportion
of live sperm released over 72 h was compared between
treatments using a student t-test. For all spermiation ana-
lyses, sperm counts were square root transformed, and
sperm proportions were arcsine transformed. The num-
ber of females ovulating in response to hormone treat-
ment (LHRHa injection) was compared to the control
treatment (saline injection) using a one-tail Fisher’s exact
test. All statistical comparisons were performed using
JMP software, with significance levels set at P < 0.05.
Results
Hormonal induction of spermiation
No frogs (0/6) released sperm following injection of a
saline control, but a high proportion of males released
sperm following injection of hCG (83.3%, 5/6) and
LHRHa (81.8%, 9/11). The number of males releasing
sperm was significantly higher in response to hormone
treatment compared to the control treatment (control
versus hCG, Fisher’s exact test: p = 0.007; control versus
LHRHa, Fisher’s exact test p = 0.002), but the number
of responding males did not significantly differ between
hormone treatments (hCG versus LHRHa, Fisher’s exact
test: p = 0.72). Males treated with hCG started releasing
sperm within 3 hrs post administration (PA), and ceased
sperm release after 48 h PA (Figure 1). In contrast,
males treated with LHRHa, did not commence sperm
release until 7 h PA, and at 72 h PA over 25% (3/11) of
males were still releasing sperm (Figure 1). The highest
proportion of males releasing sperm occurred between
12 and 48 h in response to hCG, and between 36 and
60 h in response to LHRHa (Figure 1).
The mean total number of sperm released over 72 h
was more than 11 times higher in LHRHa treated males
than in hCG treated males (Figure 2), and this difference
was significant (Welch’s ANOVA; F1, 11.06 = 11.28, P =
0.006). There was no overall time effect on the number
of sperm released (MANOVA: F 3.01, 36.15 = 1.42, p =
0.46) and no significant interaction between time and
treatment (MANOVA: F 3.01, 36.15 = 1.05, p = 0.38), indi-
cating that the number of sperm released did not differ
between treatment groups over time. However, there
was a significant treatment effect (MANOVA: F 1,12 =
8.14, p = 0.01), indicating that at each sampling period,
LHRHa treated males generally released more sperm
than hCG treated males (Table 1). Peak sperm release
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occurred at 12 h PA for hCG treated males, but not
until 36 h PA for LHRHa treated males (Table 1).
Mean total sperm concentration was significantly
higher in LHRHa treated males than in hCG treated
males (Welch’s ANOVA; F1, 11.70 = 9.33, p = 0.01, Figure
3). Sperm concentration did not significantly differ over
time (MANOVA: F 2.19, 26.32 = 2.68, p = 0.082), and there
was no significant interaction between time and treat-
ment (MANOVA: F 2.19, 26.32 = 1.79, p = 0.18), indicating
that over time sperm concentration did not differ
between treatment. However, there was a significant
overall treatment effect (MANOVA: F 1, 12 = 18.31, p =
0.001), indicating that at individual sampling times sperm
concentration was generally higher for LHRHa treated
males than hCG treated males (Table 1). Peak sperm
concentration occurred at 12 h for hCG treated males
and 36 h for LHRHa treated males, corresponding with
peaks in total sperm number (Table 1).
The mean total proportion of live sperm (sperm viabi-
lity) released over 72 h, was almost 10% higher in
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Figure 1 Percentage of hormone treated males releasing sperm over a 72 h sampling period. Frogs were administered either hCG (n = 6
males)(black bars) or LHRHa (n = 11 males)(white bars).
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LHRHa treated males than in hCG treated males (Figure
4), and this difference was significant (t-test; t = 2.31,
df = 11, p = 0.04). Males treated with hCG released live
sperm between 3 and 36 h PA, and over this period
sperm viability was generally high (>60%), but at 12 h
PA, which was the peak time for sperm release (maxi-
mum sperm number and concentration), average viabi-
lity was lower than 35% (Table 1). For LHRHa treated
males, live sperm were released between 7 and 72 h PA,
and the sperm viability remained above 60% up until 48
h PA, after which time viability started to drop (Table
1). At the time of peak sperm production and concen-
tration (36 h PA), the proportion of live sperm was
higher than 80% (Table 1).
Hormonal induction of ovulation
No frogs (0/8) released eggs following injection of a sal-
ine control, and almost 30% (5/17) of females released
eggs following injection of LHRHa, but this difference
was not significant (Fishers exact test p = 0.116). The
mean body size (SVL) of females that released eggs
(mean ± SE = 28.3 ± 0.75) was not significantly different
from females that did not release eggs (mean ± SE =
27.58 ± 0.48) (t = -0.793, df = 15, p = 0.44). There was
also no significant relationship between female body size
(SVL) and total clutch size (r2 = 0.473, n = 5, p =
0.199). Of the females that responded positively to hor-
mone treatment, all of them (5/5) released their clutches
in discrete batches over 2-4 sampling times (Table 2).
Females released between one and twelve eggs per
batch, and average total clutch size was 15.2 ± 2.67
(Table 2). No female released eggs until 24 h PA,
and only one female was still releasing eggs at 72 h PA
(Figure 5). On average, females released the greatest
proportion of their clutches between 24 and 48 h PA,
with a peak in egg release at 36 h PA (Figure 5).
In-vitro fertilisation
On average, fertilisation success across females (n = 5)
was moderate (mean ± SE = 54.72 ± 12.80%), but there
was considerable variation between females (Table 2).
Of the eggs that were fertilised, all commenced embryo-
nic development, but no embryos survived beyond gas-
trulation [44]. The exact stage of failure varied between
 Control hCG LHRHa
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Figure 2 Total number of sperm released by hormone treated males over a 72 h sampling period. Values represent mean ± SEM total
number of spermatozoa released following subcutaneous injection of i) saline solution (control, n = 6 males) ii) hCG (n = 6 males) or iii) LHRHa
(n = 11 males).
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a female’s egg batches, as well as between females
(Table 2).
Discussion
Our study showed that hormone treatment induced
gamete release in both male and female corroboree
frogs, permitting us to test whether IVF can be used to
augment captive breeding in this critically endangered
species. Spermiation was induced following administra-
tion of either hCG or LHRHa, but these hormones were
not equally effective. Both hormones led to approxi-
mately 80% of males releasing sperm, but there were
significant differences in the speed and duration of
response, and the number, concentration and proportion
of live sperm released. Administration of hCG, led to a
more rapid response, but LHRHa induced the release of
a significantly higher number and concentration of
viable sperm, and over a longer time period. This differ-
ence indicates that LHRHa was more effective at indu-
cing spermiation in this species. That hCG and LHRHa
elicited different responses was not unexpected because
past research in anurans has shown that the relative effi-
cacy of these hormones is highly species specific [5]. It
is important to recognise, that as for the vast majority
of anuran ART studies conducted to date, our study
only tested each hormone at a single dose [5]. There-
fore, to more thoroughly evaluate the relative efficacy of
each hormone, it will be necessary to establish spermia-
tion responses to hCG and LHRHa across a range of
doses. Testing dose response relationships was beyond
the scope of the current study, but this research will be
incorporated into the recovery plan for the species.
Despite our finding that LHRHa was successful at
inducing spermiation, hormone treated males did not
release exceptionally high concentrations of sperm. On
average, LHRHa treated males released approximately
4.5 × 103 sperm per millilitre, a value that is several
orders of magnitude lower than hormonally induced
sperm concentrations (4.0 × 105 to 4 × 107 sperm per
millilitre) previously reported for anurans [22,24,39].
There may be several explanations why sperm concen-
trations were comparatively low in P. corroboree. First,
the doses used may have been too low, or too high, to
induce an optimal response. Even though we used con-
centrations approximating those found to be effective in
a broad range of frog species [18,19], LHRHa may lack
potency in P. corroboree. Another possibility is that
males were not in prime physiological condition at the
time of hormone treatment. In seasonally reproducing
anurans such as P. corroboree, individuals typically
coordinate their physiological state with environmental
cues, which exert their effect by stimulating gonadotro-
pin-releasing hormone neurons at the apex of the
hypothalamus-pituitary-gonad axis [45]. In nature, sper-
matogenetic activity in P. corroboree commences several
months prior to the onset of breeding [46], so if envir-
onmental changes that normally take place in spring (e.
g. increasing photoperiod) were not suitably replicated
in the captive environment, male investment in sperma-
togenic activity may have been limited prior to treat-
ment. Another explanation for low sperm yield is that P.
corroboree is not a species that invests heavily in sper-
matogenesis. Theoretically, anurans should only experi-
ence strong selection for high sperm production if
male’s either experience a high risk of sperm competi-
tion [47], are required to fertilise large egg clutches [48],
or have exceptionally high mating rates [49], but all
these conditions are absent in P. corroboree [50,51]. In
fact, testes size relative to body size in P. corroboree is
amongst the smallest reported in the family Myobatra-
chidae [46,51], so assuming that testis size reflects
sperm production capacity in anurans [27], male P. cor-
roboree might actually be incapable of producing high
sperm yields.
For females, administration of LHRHa stimulated the
release of multiple batches of oocytes over a 24 hour
period, indicating that hormone treatment was effective
at inducing ovulation, and that final egg maturation was
asynchronous [52]. However, the average percentage of
females responding was low (<30%), and the average
clutch size (mean = approx 15 eggs) was at the lower
Table 1 Number of sperm, sperm concentration and
sperm viability of sperm released by males between 3
and 72 h post administration of hCG (n = 6) and LHRHa
(n = 11)
Treatment Time
(PA)
Sperm
number
Sperm/mL (×
103)
Sperm
viability
hCG 3 1.20 ± 1.20 0.086 ± 0.086 1.00 ± 0.00
hCG 7 0.40 ± 0.20 0.009 ± 0.005 1.00 ± 0.00
hCG 12 39.0 ± 38.25 1.72 ± 1.703 0.34 ± 0.32
hCG 24 5.00 ± 4.75 0.16 ± 0.147 0.85 ± 0.14
hCG 36 2.20 ± 1.95 0.27 ± 0.263 0.60 ± 0.40
hCG 48 9.20 ± 5.34 0.03 ± 0.022 0.00 ± 0.00
hCG 60 0.00 ± 0.00 - -
hCG 72 0.00 ± 0.00 - -
LHRHa 3 0.00 ± 0.00 - -
LHRHa 7 17.22 ± 17.22 1.111 ± 1.111 0.68 ± 0.00
LHRHa 12 101.55 ±
67.28
3.113 ± 1.837 0.89 ± 0.03
LHRHa 24 82.33 ± 47.93 3.507 ± 1.937 0.80 ± 0.08
LHRHa 36 233.88 ±
99.73
10.106 ± 4.018 0.85 ± 0.02
LHRHa 48 149.00 ±
67.42
0.776 ± 0.368 0.72 ± 0.04
LHRHa 60 67.00 ± 39.16 0.313 ± 0.162 0.30 ± 0.05
LHRHa 72 12.44 ± 6.65 0.733 ± 0.389 0.54 ± 0.24
Values represent means ± SEM
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end of the range (16-40 eggs) previously recorded for
this species [50]. The suboptimal response might mean
that LHRHa lacks potency in P. corroboree females, as
was suggested for males (see above). Indeed, the ability
of LHRHa to induce ovulation is known to vary consid-
erably between anuran species. For example, doses
required to reliably stimulate ovulation in the leptodac-
tylid frog Eleutherodactylus coqui are 25 times higher
than needed in the Wyoming toad Bufo baxteri [8,17].
Quantifying dose response relationships for female P.
corroboree, as well as for males (see above), would pro-
vide valuable insight into the potency of LHRHa in this
species. An alternative explanation is that phenotypic
differences between test females influenced their respon-
siveness to hormone treatment. For example, in a recent
study on boreal toads (Bufo boreas boreas), Roth et al.
[23] showed that female age, body size and condition
were all important factors influencing the efficacy of
LHRHa treatment. However, in our study, females were
of similar age (4-5 yrs) and there was no relationship
between female body size and number of eggs released,
so it is unlikely that these factors underpinned the vari-
able responses reported. A more plausible explanation is
that unresponsive females failed to ovulate because their
oocytes were immature at the time of hormone treat-
ment [42]. This explanation seems likely because post
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Figure 3 Total concentration of sperm released by hormone treated males over a 72 h sampling period. Values represent mean ± SEM
total concentration of spermatozoa released following subcutaneous injection of i) saline solution (control, n = 6 males) ii) hCG (n = 6 males) or
iii) LHRHa (n = 11 males).
Byrne and Silla Reproductive Biology and Endocrinology 2010, 8:144
http://www.rbej.com/content/8/1/144
Page 8 of 13
Control hCG LHRHa
0.0
0.2
0.4
0.6
0.8
1.0
Treatment
S
p
er
m
 v
ia
b
ili
ty
Figure 4 Total proportion of live sperm released (sperm viability) by hormone treated males over a 72 h sampling period. Values
represent mean ± SEM total proportion of live spermatozoa released by frogs following subcutaneous injection of i) saline solution (control, n =
6 males) ii) hCG (n = 6 males) or iii) LHRHa (n = 11 males).
Table 2 Egg release patterns and IVF success for five Pseudophryne corroboree females
Id Time (PA) Batch Total eggs % Fertilised % Survival Developmental stage at failure
3060 24 1 12 75 0 4-6
36 2 8 100 0 4-6
48 3 1 - - -
60 4 1 - - -
7 24 1 2 - - -
36 2 5 40 0 9-10
48 3 11 100 0 3-4
60 4 2 100 0 3-4
4080 36 1 4 25 0 4-6
48 2 3 0 0 3-4
809 24 1 12 41.7 0 9-10
36 2 1 0 0 -
2090 36 1 8 100 0 3-4
60 2 3 33.33 0 4-6
72 3 3 100 0 3-4
NB: For females 7 and 3060, IVF was not performed at 24 h, 48 h and 60 h respectively (missing values), because eggs were not viable when released
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experimental tactile inspection of unresponsive females
revealed that most individuals were still carrying small
to medium sized oocytes.
In nature, female P. corroboree undergo rapid oocyte
growth 4-8 weeks before the onset of breeding [46], so
assuming that similar changes take place in captivity,
our treatments may not have perfectly coincided with
the time when females were undergoing the final
stages of oogenesis. If females were treated too early,
oocytes might not have been competent for ovulation
[53], but if they were treated too late, oocytes may
have already commenced reabsorption [46]. Increasing
egg yield in P. corroboree may therefore require devel-
oping techniques for reliably assessing changes in
oocyte growth and development [54]. Furthermore, it
may be necessary to artificially accelerate and synchro-
nise ova maturation prior to any attempt to induce
ovulation. Past work with anurans has shown that this
might be achieved by repeatedly administering females
with low-dose injections of gonadotropins. For exam-
ple, Browne et al. [8] reported that two priming injec-
tions of hCG, in combination with LHRHa,
significantly increased the percentage of spawning
females, the number of oocytes released, and the sur-
vival of fertilised eggs in the Wyoming toad Bufo
baxteri.
Oocyte maturation in frogs might also be enhanced
via in vitro or in vivo treatment with steroid stimulants
[53,55]. The process of oocyte development in anurans
has been extensively studied in Xenopus laevis and Rana
pipiens and it is well established that the secretion of
progesterone from late-stage follicles plays a fundamen-
tal role in germinal vesicle breakdown (GVBD) and
oocyte maturation [55-63]. Furthermore, there is also
experimental evidence to suggest that in vivo adminis-
tration of progesterone can accelerate oocyte maturation
and increase the effectiveness of hormone treatment.
Specifically, Browne et al. [42] recently reported that
administration of progesterone, in combination with
LHRHa, significantly improved the number and quality
of hormone-induced oocytes released by the toad Bufo
fowleri. Based on these results, incorporating steroid
treatment into future ART work with P. corroboree
might be a valuable next step towards optimising ovula-
tory responses in this species.
Importantly, the hormone treatment protocols we
employed permitted gametes to be collected and IVF to
be attempted, indicating that there is real potential for
ART to assist with the captive breeding of P. corroboree.
However, the IVF trials resulted in variable levels of fer-
tilisation success. Variable fertilisation success may have
occurred because sperm concentrations were
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Figure 5 Percentage of total clutch released by female frogs (n = 5) every 12 h over a 72 h sampling period.
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suboptimal. In previous anuran ART studies, concentra-
tions of sperm resulting in high fertilisation success
have been within the range of 5 × 105 to 1 × 106 sperm
per mL [5], but we were restricted to using concentra-
tions of less than 2.8 × 102 sperm per mL, which may
have greatly reduced the probability of gamete fusion.
Alternatively, variable fertilisation success may have
resulted because the osmolality of the fertilisation med-
ium was inappropriate, as has been reported in the Aus-
tralian myobatractid frog Limnodynastes tasmaniensis
[27]. During the study all males were kept well hydrated,
so if their spermic urine was too dilute, this may have
significantly reduced the osmolality of the fertilisation
medium. If so, sperm may have been activated soon
after urine collection and lost viability before IVF was
attempted. Furthermore, if osmolality was too low this
could have resulted in the large egg capsules swelling
too rapidly, making it impossible for individual sperm to
penetrate an egg cortex. Clearly, further work will be
needed to identify the primary cause of low fertilisation
success. It may also be necessary to investigate alterna-
tive IVF techniques, such as intra-cytoplasmic sperm
injection (ICSI). This more sophisticated IVF approach
has been trialled in Bufo arenarum [64] and Xenopus
laevis [65], and provides a promising solution for
achieving high fertilisation success when numbers of
spermatozoa are limiting [7].
Of greater immediate concern than suboptimal fertili-
sation, is the result that all embryos failed during early
development. Early embryo failure may have occurred
because hormonal induction impaired gamete viability
[5]. In most studies testing the feasibility of IVF in anur-
ans, sperm has been obtained from testes macerates, and
embryo survival has been high [5,13,27-29]. However, in
a recent study in which hormonally induced sperm was
used to conduct IVF in the endangered toad Bufo bax-
teri, levels of embryo survival were also low [8]. These
results suggest that there might be problems associated
with using spermic urine to fertilize hormonally induced
oocytes. Potential reasons for this are not obvious, so
this is an area that may require research attention. An
alternative explanation for embryo failure is that the
incubation conditions employed were inappropriate for
this species. Terrestrial breeding Pseudophryne species
have extremely large and gelatinous eggs whose capsule
size and surface area is primarily determined by hydra-
tion state [66]. Consequently, the amount of water pre-
sent during incubation will significantly affect rates of
gas exchange, and subsequently, embryo growth and
survival [67]. If eggs were kept too hydrated, or were
hydrated too early in development, this may have
resulted in oxygen limitation within egg capsules, which
in turn could have resulted in embryo mortality [67].
However, this seems unlikely because our incubation
conditions were similar to those previously used to suc-
cessfully rear Pseudophryne guentheri embryos (Silla
unpublished data). As such, we suspect that there may
be a more intrinsic explanation for embryo failure.
In a recent study that used a cross classified breeding
design to examine genetic compatibility in Pseudophryne
bibronii, a sister species to P. corroboree, we discovered
that crosses made between individuals from the same
population had high embryo survival, but those made
between populations experienced complete early embryo
failure (Byrne and Silla, unpublished data). These results
indicate that terrestrial toadlets may be susceptible to
high levels of genetic incompatibility, as has been
reported in other Australian anurans [68,69]. Critically,
the frogs used in our study were all sourced from mixed
populations, so there is a real possibility that embryo
failure was indeed linked to developmental problems
arising from genetic incompatibility. To address this
potential problem, it will be necessary to conduct future
IVF trials in P. corroboree using individuals derived from
the same source populations.
Conclusion
In conclusion, this study demonstrated that exogenous
hormones induced spermiation and ovulation in the
southern corroboree frog P. corroboree. The hormone-
treatment protocols used did not lead to exceptionally
large numbers of gametes being released, but did permit
the conduction of IVF, which resulted in moderate ferti-
lisation success. Critically, however, all embryos failed
during early stages of development. Embryo develop-
mental failure may have occurred either because hor-
mone treatment compromised gamete viability or
because the incubation conditions employed were inap-
propriate. Alternatively, failure may have been linked to
genetic incompatibility resulting from crosses being
made between frogs sourced from several different
populations. Additional work will be required to
increase gamete yield for IVF and identify the causation
of embryo failure. The findings are an important first
step towards developing artificial reproductive technolo-
gies for assisting with the captive breeding of Australia’s
most critically endangered anuran.
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